Similar articles

Abstract: Objective: To investigate changes in magnetic resonance spectroscopy (MRS) of lentiform nucleus during the early stage of Parkinson's disease. Methods: Twenty-five patients with idiopathic Parkinson disease with unilateral symptoms (IPDUS) and 25 healthy volunteers were enrolled in this study. MRS of the lentiform nucleus in each patient was taken and then concentrations of N-acetylaspartate (NAA), creatine (Cr) and choline (Cho) were calculated. Results: Compared to that in the control, NAA/(Cho+Cr) was significantly lower in the lentiform nucleus contralateral to symptoms and even that in the ipsilateral side in IPDUS patients (all P<0.05); while there was no difference between the two sides in the healthy volunteer (P>0.05). The ratio of NAA/(Cho+Cr) ipsilateral to the sympatomatic side of the patient was also lower than that of the control (P<0.05). Conclusions: there might be some changes with MRS on the lentiform nucleus during the early stage of idiopathic Parkinson's disease with unilateral symptom. MRS may be one of the reliable methods for early or even sub-clinical diagnosis.

[1] Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., Seitelberger, F., 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.J Neurol Sci.,20(4):415-455.

[2] Brooks, D.J., 2000. Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease.J Neurol,247(2):II11-8.

[3] Choe, B.Y., Park, J.W., Lee, K.S., Son, B.C., Kim, M.C., Kim, B.S., Suh, T.S., Lee, H.K., Shinn, K.S., 1998. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.Invest Radiol.,33(8):450-455.

[4] Ellis, C.M., Lemmens, G., Williams, S.C., Simmons, A., Dawson, J., Leigh, P.N., Chaudhuri, K.R., 1997. Changes in putamen N-acetylaspartate and Choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.Neurology.,49(2):438-444.

[5] Frost, J.J., Rosier, A.J., Reich, S.G., Smith, J.S., Ehlers, M.D., Snyder, S.H., Ravert, H.T., Dannals, R.F., 1993. Positron emission tomographic imagine of the dopamine transporter with 11C-win 35 428 reveals marked declines mild Parkinson's disease.Ann Neurol,34:423-431.

[6] Iranzo, A., Moreno, A., Pujol, J., Marti-Fabregas, J., Domingo, P., Molet, J., Ris, J., Cadafalch, J., 1999. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS.J Neurol Neurosurg Psychiatry.66(4):520-523.

[7] National Extrapyramidal Session, 1986. The diagnosis criteria and differential diagnosis of Parkinson's disease and Parkinson's syndromes .Chin J Neurol Psychiatry,19(5):256(in Chinese).

[8] Otsuka, M., Ichiya, Y., Kuwabara, Y., 1996. Differences in the reduced18F-dopa uptakes of the caudate and putamen in Parkinson's disease: correlations with the three main symptoms.J Neurol Sci,136:169-173.

[9] Ronald, F., 1990. Therapy of Parkinson's Disease. Marcel Dekker Inc, New York, p.95-120.